{
    "Orphapacket": {
        "ORPHApacketId": "615964",
        "creationDate": "2025-06-26 11:48:15",
        "version": "1.3.42 / 4.1.8 [2025-03-03]",
        "copyright": "Orphanet (c) 2025",
        "ORPHAcode": "615964",
        "Label": "Acute reversible leukoencephalopathy with increased urinary alpha-ketoglutarate",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_615964",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "Synonyms": [
            {
                "Synonym": "Acute reversible leukoencephalopathy due to SLC13A3 deficiency"
            },
            {
                "Synonym": "Acute reversible leukoencephalopathy due to sodium-dependent dicarboxylate transporter deficiency"
            }
        ],
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "618384",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare neurometabolic disease characterized by acute reversible and sometimes recurrent neurologic deterioration (including drowsiness hypotonia dysarthria and ataxia) during a febrile illness. The condition is associated with reversible leukoencephalopathy and persistently increased urinary excretion (and sometimes cerebrospinal fluid concentration) mainly of alpha-ketoglutarate and N-acetylaspartate."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "68385",
                        "Label": "Neurometabolic disease"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "254749",
                        "Label": "Tricarboxylic acid cycle disorder"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "38235040[PMID]",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case(s)",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "38235040[PMID]_ORPHANET",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adult"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Childhood"
                }
            }
        ]
    }
}